PharmiWeb

Viral Vector Manufacturing Market Growth, Segments, Size, Market Analysis and Opportunities 2030

The global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
Business Wire

VectorY Therapeutics Receives FDA Clearance of IND to Proceed with the PIONEER-ALS Phase 1/2 Trial of VTx-002, a First-in-Class Vectorized Antibody Targeting TDP-43 Pathology ...

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) ...
Business Wire

Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced ...
IEEE

VQ-Flow: Taming Normalizing Flows for Multi-Class Anomaly Detection via Hierarchical Vector Quantization

Abstract: Normalizing flows, a category of probabilistic models famed for their capabilities in modeling complex data distributions, have exhibited remarkable efficacy in unsupervised anomaly ...
Daily Herald

UVU to reopen campus in phases, resume classes Wednesday

Utah Valley University announced Friday a plan to return to class after the assassination of Charlie Kirk on campus Wednesday forced the school’s closure through the weekend. UVU President Astrid S.
TheServerSide

Java array size, length and loop examples

Community driven content discussing all aspects of software development from DevOps to design patterns. Here are the most important concepts developers must know when they size Java arrays and deal ...
InfoWorld

Enter the parallel universe of Java’s Vector API

The Vector API gives Java developers everything they need to tap into CPU-level performance gains for numerically intensive operations. If there is one thing you can describe as an obsession for both ...
BioSpace

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford, UK – 20 February 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that its proprietary lentiviral vector manufacturing technology will be ...